We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Preclinical Data Could Have Shown Experimental Drug Was Risky
Preclinical Data Could Have Shown Experimental Drug Was Risky
November 1, 2006
Data from preclinical animal experiments that preceded the calamitous clinical trial of the experimental gene therapy TGN1412 suggest that the drug should have been classified as higher risk than it actually was, and the trial participants should have received a lower dose, according to two researchers writing in the UK medical journal The Lancet.